1
|
Kilickesmez K, Dall'Ara G, Rama-Merchan JC, Ghione M, Mattesini A, Vinues CM, Konstantinidis N, Pighi M, Estevez-Loureiro R, Zivelonghi C, Lindsay AC, Secco GG, Foin N, De Silva R, Di Mario C. Optical coherence tomography characteristics of in-stent restenosis are different between first and second generation drug eluting stents. INTERNATIONAL JOURNAL OF CARDIOLOGY. HEART & VESSELS 2014; 3:68-74. [PMID: 29450174 PMCID: PMC5801271 DOI: 10.1016/j.ijchv.2014.03.003] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/15/2014] [Accepted: 03/10/2014] [Indexed: 11/26/2022]
Abstract
Aims Characterization of neointimal tissue is essential to understand the pathophysiology of in-stent restenosis (ISR) after drug eluting stent (DES) implantation. Using optical coherence tomography (OCT), we compared the morphologic characteristics of ISR between first and second generation DES. Methods and Results OCT was performed in 66 DES-ISR, defined as > 50% angiographic diameter stenosis within the stented segment. Patients with ISR of first generation sirolimus-eluting stents (SES), paclitaxel eluting stents (PES) and second generation zotarolimus-eluting stents (ZES), everolimus-eluting stents (EES) and biolimus-eluting stents (BES) were enrolled. Quantitative and qualitative ISR tissue analysis was performed at 1-mm intervals along the entire stent, and categorised as homogeneous, heterogeneous and neo-atherosclerosis. The presence of microvessels and peri-strut low intensity area (PSLIA) was determined in all ISR. Neoatherosclerosis was identified by lipid, calcium and thin-cap fibro-atheroma (TCFA) like lesions. We compared the two DES generations at both early (< 1 year) and late (> 1 year) follow-ups. In second generation DES a heterogeneous pattern was prevalent both before and after 1 year (57.1% and 58.6% respectively). Neo-atherosclerosis was more common in the early period in first generation DES (19.4% vs 11.7%, p < 0.01), but after one year was more prevalent in second generation DES (7.0% vs 19.3%, p < 0.01). Similar prevalence of TCFAs was observed in both groups in all comparisons. Conclusions When ISR restenosis occurs in second generation DES, the current data suggest a different time course and different morphological characteristics from first generation. Future prospective studies should evaluate the relationship between ISR morphology, time course and clinical events.
Collapse
Affiliation(s)
- Kadriye Kilickesmez
- NIHR Biomedical Research Unit, Royal Brompton Hospital & Harefield NHS Foundation Trust, London, UK
| | - Gianni Dall'Ara
- NIHR Biomedical Research Unit, Royal Brompton Hospital & Harefield NHS Foundation Trust, London, UK
| | - Juan Carlos Rama-Merchan
- NIHR Biomedical Research Unit, Royal Brompton Hospital & Harefield NHS Foundation Trust, London, UK
| | - Matteo Ghione
- NIHR Biomedical Research Unit, Royal Brompton Hospital & Harefield NHS Foundation Trust, London, UK
| | - Alessio Mattesini
- NIHR Biomedical Research Unit, Royal Brompton Hospital & Harefield NHS Foundation Trust, London, UK
| | - Carlos Moreno Vinues
- NIHR Biomedical Research Unit, Royal Brompton Hospital & Harefield NHS Foundation Trust, London, UK
| | - Nikolaos Konstantinidis
- NIHR Biomedical Research Unit, Royal Brompton Hospital & Harefield NHS Foundation Trust, London, UK
| | - Michele Pighi
- NIHR Biomedical Research Unit, Royal Brompton Hospital & Harefield NHS Foundation Trust, London, UK
| | - Rodrigo Estevez-Loureiro
- NIHR Biomedical Research Unit, Royal Brompton Hospital & Harefield NHS Foundation Trust, London, UK
| | - Carlo Zivelonghi
- NIHR Biomedical Research Unit, Royal Brompton Hospital & Harefield NHS Foundation Trust, London, UK
| | - Alistair C Lindsay
- NIHR Biomedical Research Unit, Royal Brompton Hospital & Harefield NHS Foundation Trust, London, UK
| | - Gioel G Secco
- NIHR Biomedical Research Unit, Royal Brompton Hospital & Harefield NHS Foundation Trust, London, UK.,Department of Clinical and Experimental Medicine, University of Eastern Piedmont, Novara, Italy
| | - Nicolas Foin
- National Heart and Lung Institute, Imperial College London, London, UK
| | - Ranil De Silva
- NIHR Biomedical Research Unit, Royal Brompton Hospital & Harefield NHS Foundation Trust, London, UK.,National Heart and Lung Institute, Imperial College London, London, UK
| | - Carlo Di Mario
- NIHR Biomedical Research Unit, Royal Brompton Hospital & Harefield NHS Foundation Trust, London, UK.,National Heart and Lung Institute, Imperial College London, London, UK
| |
Collapse
|
5
|
de Kleijn DP, Moll FL, Hellings WE, Ozsarlak-Sozer G, de Bruin P, Doevendans PA, Vink A, Catanzariti LM, Schoneveld AH, Algra A, Daemen MJ, Biessen E, de Jager W, Zhang H, de Vries JP, Falk E, Lim SK, van der Spek PJ, Sze SK, Pasterkamp G. Local Atherosclerotic Plaques Are a Source of Prognostic Biomarkers for Adverse Cardiovascular Events. Arterioscler Thromb Vasc Biol 2010; 30:612-9. [DOI: 10.1161/atvbaha.109.194944] [Citation(s) in RCA: 93] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Objective—
Atherosclerotic cardiovascular disease is a major burden to health care. Because atherosclerosis is considered a systemic disease, we hypothesized that one single atherosclerotic plaque contains ample molecular information that predicts future cardiovascular events in all vascular territories.
Methods and Results—
AtheroExpress is a biobank collecting atherosclerotic lesions during surgery, with a 3-year follow-up. The composite primary outcome encompasses all cardiovascular events and interventions, eg, cardiovascular death, myocardial infarction, stroke, and endovascular interventions. A proteomics search identified osteopontin as a potential plaque biomarker. Patients undergoing carotid surgery (n=574) served as the cohort in which plaque osteopontin levels were examined in relation to their outcome during follow-up and was validated in a cohort of patients undergoing femoral endarterectomy (n=151). Comparing the highest quartile of carotid plaque osteopontin levels with quartile 1 showed a hazard ratio for the primary outcome of 3.8 (95% confidence interval, 2.6–5.9). The outcome did not change after adjustment for plaque characteristics and traditional risk factors (hazard ratio, 3.5; 95% confidence interval, 2.0–5.9). The femoral validation cohort showed a hazard ratio of 3.8 (95% confidence interval 2.0 to 7.4) comparing osteopontin levels in quartile 4 with quartile 1.
Conclusion—
Plaque osteopontin levels in single lesions are predictive for cardiovascular events in other vascular territories. Local atherosclerotic plaques are a source of prognostic biomarkers with a high predictive value for secondary manifestations of atherosclerotic disease.
Collapse
Affiliation(s)
- Dominique P.V. de Kleijn
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Frans L. Moll
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Willem E. Hellings
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Gonen Ozsarlak-Sozer
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Peter de Bruin
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Pieter A. Doevendans
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Aryan Vink
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Louise M. Catanzariti
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Arjan H. Schoneveld
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Ale Algra
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Mat J. Daemen
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - E.A. Biessen
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - W. de Jager
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Huoming Zhang
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Jean-Paul de Vries
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Erling Falk
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Sai K. Lim
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Peter J. van der Spek
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Siu Kwan Sze
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| | - Gerard Pasterkamp
- From Experimental Cardiology (D.P.V.d.K., W.E.H., G.O.-S., L.M.C., A.H.S., G.P.), Cardiology, DH&L, UMC Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (D.P.V.d.K., A.H.S.), Utrecht, the Netherlands; Genome Institute of Singapore (D.P.V.d.K.), Singapore; Department of Vascular Surgery (F.L.M., W.E.H.), UMC Utrecht, the Netherlands; Department of Pharmacology (G.O.-S.), Faculty of Pharmacy, Ege University, Izmir, Turkey; Department of Pathology (P.d.B.), St
| |
Collapse
|